Cerus vs Orthopediatrics
Cerus and Orthopediatrics are similar in size: $234m and $236m of revenue in their latest fiscal years. Cerus grew faster (16.1% against 15.4%). Cerus kept more of each dollar of sales as profit: a net margin of -6.7% against -16.8%.
| Latest fiscal year | CerusCERS, 2025 | OrthopediatricsKIDS, 2025 |
|---|---|---|
| Revenue | $234m | $236m |
| Revenue growth | 16.1% | 15.4% |
| Net income | −$15.6m | −$39.6m |
| Operating margin | -3.7% | — |
| Net margin | -6.7% | -16.8% |
| Return on equity | -26.0% | -11.3% |
| Free cash flow | $1.1m | −$16.0m |
| Cash | $20.0m | $19.6m |
| Total debt | $84.0m | $106m |
| Debt to equity | 130.7% | — |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | 275 | 602 |
| Market value | $472m | $750m |
| Price vs our value range | — | — |
| Moat score | 21 (Weak) | 35 (Weak) |
| Insider trades, 12 months | 0 buys, 25 sales | 0 buys, 0 sales |